It has been shown that ARL4C promotes migration, invasion and proliferation in colorectal and lung cancer34, and recent genome-wide CRISPR-Cas9 inhibition screens revealed that ARL4C is essential for the proliferation of PFA ependymoma compared to glioblastoma cell lines29,30. This evidence concerns the gene ARL4C and ependymoma.